Amgen Inc vs Abbvie Inc.
AMGN vs ABBV — side-by-side comparison from reported financials. AMGN leads 7, ABBV leads 5 of 12 comparable metrics.
Amgen Inc
AMGN · Healthcare
$415.01+1.86%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | AMGN | ABBV |
|---|---|---|
| Price | $415.01 | $276.43 |
| Market cap | $224B | $488B |
| Revenue (TTM) | $38.1B | $64.4B |
| Revenue growth | +11.8% | +1.8% |
| Net margin | 23.0% | 9.8% |
| Free cash flow | $10.2B | $18.2B |
| Net cash (debt) | ($40.9B) | ($56.2B) |
| 1-year price return | +40.5% | +19.8% |
| P/E | 25.7 | 77.4 |
| P/E vs own history (cheap-side %) | 35% | 23% |
| Dividend yield | 2.32% | 2.45% |
| Return on equity | 89% | 96% |
| Altman Z-score | 1.81 | 2.33 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 31,500 | 57,000 |
Full résumé-style profiles: AMGN CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.